<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1445" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1445/" /><meta name="ncbi_pagename" content="Townes-Brocks Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Townes-Brocks Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Townes-Brocks Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/01/14" /><meta name="citation_author" content="Jürgen Kohlhase" /><meta name="citation_pmid" content="20301618" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1445/" /><meta name="citation_keywords" content="Sal-like protein 1" /><meta name="citation_keywords" content="SALL1" /><meta name="citation_keywords" content="Townes-Brocks Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Townes-Brocks Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Jürgen Kohlhase" /><meta name="DC.Date" content="2016/01/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1445/" /><meta name="description" content="Townes-Brocks syndrome (TBS) is characterized by the triad of imperforate anus (84%), dysplastic ears (87%; overfolded superior helices and preauricular tags; frequently associated with sensorineural and/or conductive hearing impairment [65%]), and thumb malformations (89%; triphalangeal thumbs, duplication of the thumb [preaxial polydactyly], and rarely hypoplasia of the thumbs). Renal impairment (42%), including end-stage renal disease (ESRD), may occur with or without structural abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, polycystic kidneys, vesicoutereral reflux). Congenital heart disease occurs in 25%. Foot malformations (52%; flat feet, overlapping toes) and genitourinary malformations (36%) are common. Intellectual disability occurs in approximately 10% of individuals. Rare features include iris coloboma, Duane anomaly, Arnold-Chiari malformation type 1, and growth retardation." /><meta name="og:title" content="Townes-Brocks Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Townes-Brocks syndrome (TBS) is characterized by the triad of imperforate anus (84%), dysplastic ears (87%; overfolded superior helices and preauricular tags; frequently associated with sensorineural and/or conductive hearing impairment [65%]), and thumb malformations (89%; triphalangeal thumbs, duplication of the thumb [preaxial polydactyly], and rarely hypoplasia of the thumbs). Renal impairment (42%), including end-stage renal disease (ESRD), may occur with or without structural abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, polycystic kidneys, vesicoutereral reflux). Congenital heart disease occurs in 25%. Foot malformations (52%; flat feet, overlapping toes) and genitourinary malformations (36%) are common. Intellectual disability occurs in approximately 10% of individuals. Rare features include iris coloboma, Duane anomaly, Arnold-Chiari malformation type 1, and growth retardation." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1445/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/tbs/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1445/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C820FE03F94C1000000000B1603CF.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1445_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1445_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/timothy/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tcs/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1445_"><span class="title" itemprop="name">Townes-Brocks Syndrome</span></h1><p class="contrib-group"><span itemprop="author">J&#x000fc;rgen Kohlhase</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1445_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1445_ai__"><div class="contrib half_rhythm"><span itemprop="author">J&#x000fc;rgen Kohlhase</span>, MD<div class="affiliation small">Center for Human Genetics<br />Freiburg, Germany<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ed.grubierf-kitenegnamuh@esahlhokj" class="oemail">ed.grubierf-kitenegnamuh@esahlhokj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 24, 2007</span>; Last Update: <span itemprop="dateModified">January 14, 2016</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="tbs.Summary" itemprop="description"><h2 id="_tbs_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Townes-Brocks syndrome (TBS) is characterized by the triad of imperforate anus (84%), dysplastic ears (87%; overfolded superior helices and preauricular tags; frequently associated with sensorineural and/or conductive hearing impairment [65%]), and thumb malformations (89%; triphalangeal thumbs, duplication of the thumb [preaxial polydactyly], and rarely hypoplasia of the thumbs). Renal impairment (42%), including end-stage renal disease (ESRD), may occur with or without structural abnormalities (mild malrotation, ectopia, horseshoe kidney, renal hypoplasia, polycystic kidneys, vesicoutereral reflux). Congenital heart disease occurs in 25%. Foot malformations (52%; flat feet, overlapping toes) and genitourinary malformations (36%) are common. Intellectual disability occurs in approximately 10% of individuals. Rare features include iris coloboma, Duane anomaly, Arnold-Chiari malformation type 1, and growth retardation.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of TBS is based on clinical findings; identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> establishes the diagnosis if clinical features are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Immediate surgical intervention for imperforate anus; early treatment of hearing loss; surgery for severe malformations of the hands; hemodialysis and possibly kidney transplantation for ESRD; surgery or medical treatment by a cardiologist for <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects.</p><p><i>Surveillance</i>: Annual hearing evaluation; regular monitoring of renal function in individuals with and without renal anomalies, even if renal function is normal on initial examination.</p><p><i>Agents/circumstances to avoid:</i> Medications that cause renal or otic toxicity.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>TBS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is estimated at 50%. Each child of an individual with TBS caused by a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant has been identified in the family.</p></div></div><div id="tbs.Diagnosis"><h2 id="_tbs_Diagnosis_">Diagnosis</h2><div id="tbs.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Townes-Brocks syndrome (TBS) should be suspected in individuals with the following major and minor clinical features.</p><p><b>Major features</b></p><ul><li class="half_rhythm"><div>Imperforate anus or anal stenosis in 84%</div></li><li class="half_rhythm"><div>Dysplastic ears in 87% (overfolded superior helices, microtia)</div></li><li class="half_rhythm"><div>Typical thumb malformations in 89% (preaxial polydactyly, triphalangeal thumbs, hypoplastic thumbs) without hypoplasia of the radius</div></li></ul><p><b>Minor features</b></p><ul><li class="half_rhythm"><div>Sensorineural and/or conductive hearing impairment</div></li><li class="half_rhythm"><div>Foot malformations</div></li><li class="half_rhythm"><div>Renal impairment with or without renal malformations</div></li><li class="half_rhythm"><div>Genitourinary malformations</div></li><li class="half_rhythm"><div>Congenital heart disease</div></li></ul><p><b>Atypical (not suggestive of TBS)</b></p><ul><li class="half_rhythm"><div>Radius hypoplasia on clinical examination or radiographs</div></li><li class="half_rhythm"><div>Cleft lip/palate</div></li></ul></div><div id="tbs.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of TBS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with three major features. If only two major features are present, the presence of minor features and the absence of atypical features further support the diagnosis. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1445/table/tbs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figtbsTmoleculargenetictestingusedin" rid-ob="figobtbsTmoleculargenetictestingusedin">Table 1</a>) establishes the diagnosis if clinical features are inconclusive.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>SALL1</i> is performed first followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SALL1</i> and other genes of interest may also be considered. The genes included in multigene panels vary by laboratory and are likely to change over time. However, due to the existence of a highly homologous <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pseudogene/">pseudogene</a> (<i>SALL1P1</i>), capture-based <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> panels may not be the optimal choice.</div><div class="half_rhythm">Note: (1) A few individuals with clinical features of TBS have been found to have pathogenic variants in <i>SALL4</i> [<a class="bk_pop" href="#tbs.REF.kohlhase.2002.2979">Kohlhase et al 2002</a>; <a class="bk_pop" href="#tbs.REF.borozdin.2004.e102">Borozdin et al 2004</a>; Kohlhase, personal communication]. Therefore, in individuals with a diagnosis of TBS and negative <i>SALL1</i> testing, <i>SALL4</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be considered. (2) Molecular genetic testing of <i>SALL4</i> rather than <i>SALL1</i> is suggested as the first molecular test if the radius is involved and/or if Duane anomaly is present. See <a href="#tbs.Differential_Diagnosis">Differential Diagnosis</a>, <b>Okihiro syndrome</b> and <a href="/books/n/gene/drrs/"><i>SALL4</i>-Related Disorders</a>.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) fails to confirm a diagnosis in an individual with features of TBS. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="tbs.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Townes-Brocks Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1445/table/tbs.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbs.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SALL1</i></td><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~70%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_tbs.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="tbs.TF.1.1"><p class="no_margin">See <a href="/books/NBK1445/#tbs.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="tbs.TF.1.2"><p class="no_margin">See <a href="#tbs.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="tbs.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="tbs.TF.1.4"><p class="no_margin">Sequence analysis has detected pathogenic variants in more than 100 individuals with Townes-Brocks syndrome [<a class="bk_pop" href="#tbs.REF.kohlhase.1998.81">Kohlhase et al 1998</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.marlin.1999.377">Marlin et al 1999</a>, <a class="bk_pop" href="#tbs.REF.blanck.2000.303">Blanck et al 2000</a>, <a class="bk_pop" href="#tbs.REF.engels.2000.458">Engels et al 2000</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.2000.460">Kohlhase 2000</a>, <a class="bk_pop" href="#tbs.REF.salerno.2000.25">Salerno et al 2000</a>, <a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>, <a class="bk_pop" href="#tbs.REF.devriendt.2002.230">Devriendt et al 2002</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.2003.e127">Kohlhase et al 2003</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>, <a class="bk_pop" href="#tbs.REF.walter.2006.649">Walter et al 2006</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>]. Sequence analysis in about 70% and <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing in about 5% identify a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or deletion in approximately 75% of persons with the classic triad of malformations as described by <a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al [1999]</a>.</p></div></dd><dt>5. </dt><dd><div id="tbs.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="tbs.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#tbs.REF.borozdin.2006.211">Borozdin et al [2006]</a> identified three and <a class="bk_pop" href="#tbs.REF.bardakjian.2009.137">Bardakjian et al [2009]</a> and <a class="bk_pop" href="#tbs.REF.miller.2012.533">Miller et al [2012]</a> identified two further multiexon/whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions.</p></div></dd><dt>7. </dt><dd><div id="tbs.TF.1.7"><p class="no_margin">A <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been found in a number of individuals with the classic TBS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; thus, <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> heterogeneity appears likely.</p></div></dd></dl></div></div></div></div></div><div id="tbs.Clinical_Characteristics"><h2 id="_tbs_Clinical_Characteristics_">Clinical Characteristics</h2><p>In the two most recent studies [<a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>] of 61 persons with novel <i>SALL1</i> pathogenic variants (not including the most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, p.Arg276Ter), 84% had anal anomalies, 89% hand anomalies, and 87% ear anomalies; 67% had the characteristic triad.</p><div id="tbs.Clinical_Description"><h3>Clinical Description</h3><ul><li class="half_rhythm"><div><b>Gastrointestinal.</b> Imperforate anus, anal stenosis, chronic constipation, gastroesophageal reflux [<a class="bk_pop" href="#tbs.REF.engels.2000.458">Engels et al 2000</a>]</div></li><li class="half_rhythm"><div><b>Dysplastic ears</b> (overfolded superior helices, microtia), <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> sensorineural and/or conductive hearing loss ranging from mild to severe. Hearing loss that is mild may worsen with age (65% of individuals).</div></li><li class="half_rhythm"><div><b>Thumb malformations.</b> Preaxial polydactyly, triphalangeal thumbs, and hypoplastic thumbs without hypoplasia of the radius</div></li><li class="half_rhythm"><div><b>Lower extremities.</b> Clubfoot, overlapping toes (II and IV over III), syndactyly of toes, missing toes (III) (52% of individuals) [<a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>]</div></li><li class="half_rhythm"><div><b>Kidneys.</b> Renal agenesis, renal hypoplasia, polycystic kidneys; functional impairment with or without structural abnormalities (42% of individuals) [<a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>]</div></li><li class="half_rhythm"><div><b>Genitourinary.</b> Hypospadias, vaginal aplasia with bifid uterus, bifid scrotum, cryptorchidism (36% of individuals) [<a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>]</div></li><li class="half_rhythm"><div><b>Heart.</b> Congenital heart disease in 50% of persons with the common p.Arg276Ter <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#tbs.REF.kohlhase.2003.e127">Kohlhase et al 2003</a>] and 12%-25% of persons with other <i>SALL1</i> pathogenic variants [<a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>]. Defects include atrial septal defect, ventricular septal defect, tetralogy of Fallot, lethal truncus arteriosus, pulmonary valve atresia, and persistent ductus arteriosus [<a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>].</div></li><li class="half_rhythm"><div><b>Central nervous system</b></div><ul><li class="half_rhythm"><div>Intellectual disability (~10%)</div></li><li class="half_rhythm"><div>Behavioral problems, observed in many children with TBS [Kohlhase, unpublished observations]</div></li><li class="half_rhythm"><div>Arnold-Chiari malformation type I [Kohlhase, unpublished observations]</div></li><li class="half_rhythm"><div>Cranial nerve palsy (nerves VI and VII)</div></li><li class="half_rhythm"><div>Duane anomaly. Uni- or bilateral limitation of abduction of the eye associated with retraction of the globe and narrowing of the palpebral fissure on adduction. The abducens nucleus and nerve (cranial nerve VI) are absent and the lateral rectus muscle is innervated by a branch of the oculomotor nerve (cranial nerve III), accounting for the aberrant ocular movements.</div></li><li class="half_rhythm"><div>Hypoplasia of the dorsal part of corpus callosum</div></li></ul></li><li class="half_rhythm"><div><b>Growth.</b> Postnatal growth retardation. This poorly documented feature has been described in fewer than 6% to 29% of persons reported with TBS in the literature [<a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>]. The occurrence of postnatal growth retardation among individuals with a confirmed <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not known. <a class="bk_pop" href="#tbs.REF.lawrence.2013.2266">Lawrence et al [2013]</a> reported growth hormone deficiency in an individual with TBS, suggesting that this may also be the cause for growth retardation in other individuals with TBS.</div></li><li class="half_rhythm"><div><b>Skeletal.</b> Rib anomalies (fused ribs, missing ribs, additional cervical ribs), mild vertebral anomalies (9%). Painful joints have been observed in several adults with TBS [Kohlhase, unpublished observations].</div></li><li class="half_rhythm"><div><b>Eyes.</b> Microphthalmia (rare), iris coloboma, lamellar cataract, chorioretinal coloboma with loss of vision</div></li><li class="half_rhythm"><div><b>Face.</b> Hemifacial microsomia [<a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.keegan.2001.310">Keegan et al 2001</a>]</div></li><li class="half_rhythm"><div><b>Endocrine.</b> Congenital hypothyroidism (rare) [<a class="bk_pop" href="#tbs.REF.lawrence.2013.2266">Lawrence et al 2013</a>]</div></li></ul></div><div id="tbs.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been made for the majority of pathogenic variants, most of which are <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a>.</p><p>The most common <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the only pathogenic variant found in more than two families is c.826C&#x0003e;T (p.Arg276Ter), detected in approximately half of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases with TBS (i.e., a single occurrence in a family) and in one <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> case to date [<a class="bk_pop" href="#tbs.REF.kohlhase.2003.e127">Kohlhase et al 2003</a>]. This pathogenic variant is associated with greater frequency (50%) and severity of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defects than other pathogenic variants. Fifteen of 16 individuals with this pathogenic variant showed the characteristic triad of anal, thumb, and ear malformations (94%), indicating that this pathogenic variant is associated with a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>In general, pathogenic variants within the <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> region that is towards the 5' end in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 appear to be associated with a more severe outcome than pathogenic variants towards the 3' in exon 2. In addition, the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> associated with deletions of <i>SALL1</i> appears to be milder than that associated with pathogenic variants in the hot spot region, but only five families with larger deletions have been reported to date [<a class="bk_pop" href="#tbs.REF.borozdin.2006.211">Borozdin et al 2006</a>, <a class="bk_pop" href="#tbs.REF.bardakjian.2009.137">Bardakjian et al 2009</a>, <a class="bk_pop" href="#tbs.REF.miller.2012.533">Miller et al 2012</a>].</p></div><div id="tbs.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be complete, but expressivity is highly variable.</p></div><div id="tbs.Anticipation"><h3>Anticipation</h3><p>Apparent increased severity in successive generations is likely attributable to ascertainment bias.</p></div><div id="tbs.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#tbs.REF.feichtiger.1943">Feichtiger [1943]</a> provided one of the earliest reports of Townes-Brocks syndrome.</p><p><a class="bk_pop" href="#tbs.REF.townes.1972.321">Townes &#x00026; Brocks [1972]</a> were the first to report <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> transmission of the characteristic anomalies.</p><p><a class="bk_pop" href="#tbs.REF.kurnit.1978.270">Kurnit et al [1978]</a> used the term REAR syndrome (for <i>r</i>enal, <i>e</i>ar, <i>a</i>nal, and <i>r</i>adial malformations).</p><p><a class="bk_pop" href="#tbs.REF.monteiro_de_pinaneto.1984.147">Monteiro de Pina-Neto [1984]</a> was the first to use the term Townes-Brocks syndrome.</p></div><div id="tbs.Prevalence"><h3>Prevalence</h3><p>The prevalence is unknown, partly because the clinical diagnosis of Townes-Brocks syndrome is often complicated by overlap with VACTERL association, which may lead to an over-ascertainment of TBS prevalence. Mart&#x000ed;nez-Fr&#x000ed;as estimated the prevalence at 1:250,000 but did not use stringent diagnostic criteria for TBS [<a class="bk_pop" href="#tbs.REF.mart_nezfr_as.1999">Mart&#x000ed;nez-Fr&#x000ed;as et al 1999</a>].</p></div></div><div id="tbs.Genetically_Related_Allelic_Disorder"><h2 id="_tbs_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>A <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant, p.Arg1054Ter, was reported to cause a more severe TBS-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> combined with severe neurologic defects. This variant does not cause a phenotype in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state [<a class="bk_pop" href="#tbs.REF.vodopiutz.2013.612">Vodopiutz et al 2013</a>].</p></div><div id="tbs.Differential_Diagnosis"><h2 id="_tbs_Differential_Diagnosis_">Differential Diagnosis</h2><p>The clinical presentation of Townes-Brocks syndrome (TBS) can overlap with Goldenhar syndrome (hemifacial microsomia) [<a class="bk_pop" href="#tbs.REF.gabrielli.1993.459">Gabrielli et al 1993</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.keegan.2001.310">Keegan et al 2001</a>], Okihiro syndrome (but without malformations of the radius) [<a class="bk_pop" href="#tbs.REF.borozdin.2004.e102">Borozdin et al 2004</a>], and branchiootorenal syndrome [<a class="bk_pop" href="#tbs.REF.engels.2000.458">Engels et al 2000</a>, <a class="bk_pop" href="#tbs.REF.albrecht.2004.102">Albrecht et al 2004</a>]. TBS also overlaps with VACTERL association.</p><p><b>Goldenhar syndrome.</b> The majority of individuals with oculo-auriculo-vertebral spectrum phenotypes do not have upper-limb or anal malformations. However, some persons with <i>SALL1</i> pathogenic variants have <a href="/books/n/gene/m-hfm-ov/">hemifacial microsomia</a>. [<a class="bk_pop" href="#tbs.REF.gabrielli.1993.459">Gabrielli et al 1993</a>, <a class="bk_pop" href="#tbs.REF.johnson.1996.134">Johnson et al 1996</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.keegan.2001.310">Keegan et al 2001</a>]. Therefore, while hemifacial microsomia alone is not suggestive of the presence of a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it may occur in individuals with a <i>SALL1</i> pathogenic variant in addition to more typical TBS malformations.</p><p><b>Okihiro syndrome (Duane-radial ray syndrome)</b> is characterized by Duane anomaly and radial ray defects, and less commonly by hearing loss and renal position anomalies (see <a href="/books/n/gene/drrs/"><i>SALL4</i>-Related Disorders</a>).</p><ul><li class="half_rhythm"><div>In a few individuals with clinical TBS, causative <i>SALL4</i> variants were found instead of <i>SALL1</i> [<a class="bk_pop" href="#tbs.REF.kohlhase.2002.2979">Kohlhase et al 2002</a>; <a class="bk_pop" href="#tbs.REF.borozdin.2004.e102">Borozdin et al 2004</a>; Kohlhase, personal communication]. In those individuals, both <i>SALL1</i> and <i>SALL4</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be considered.</div></li><li class="half_rhythm"><div>Duane anomaly can also occur with a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>].</div></li><li class="half_rhythm"><div>Because radial aplasia or hypoplasia and thumb aplasia have not been observed in individuals with a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [Kohlhase, unpublished data], their presence points toward a <i>SALL4</i> pathogenic variant, even if all other features suggest TBS.</div></li></ul><p><a href="/books/n/gene/bor/"><b>Branchiootorenal (BOR) syndrome</b></a><b>.</b> In two families eventually determined to have <i>SALL1</i> pathogenic variants, no <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had the typical triad of thumb, anal, and ear malformations. Instead, the presence of dysplastic ears and renal malformations or impaired renal function in family members initially led to the consideration of BOR syndrome [<a class="bk_pop" href="#tbs.REF.engels.2000.458">Engels et al 2000</a>, <a class="bk_pop" href="#tbs.REF.albrecht.2004.102">Albrecht et al 2004</a>].</p><p><b>VACTERL association</b> (OMIM <a href="http://omim.org/entry/192350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">192350</a>) comprises <i>v</i>ertebral defects, <i>a</i>nal atresia, <i>c</i>ardiac defects, <i>t</i>racheo-<i>e</i>sophageal fistula, <i>r</i>enal malformations, and <i>l</i>imb defects. VACTERL is therefore an important differential diagnosis for <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in a family) with suspected TBS. To date, severe vertebral defects and tracheo-esophageal fistula have not been observed in persons with a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [Kohlhase, unpublished data]. Sib and offspring recurrence risks for VACTERL association are estimated at approximately 1%. A review summarizes current information on VACTERL association [<a class="bk_pop" href="#tbs.REF.shawsmith.2006.545">Shaw-Smith 2006</a>].</p><p><b>STAR syndrome</b> (OMIM <a href="http://omim.org/entry/300707" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300707</a>) is characterized by toe syndactyly, telecanthus, anogenital malformations, and renal malformations similar to TBS. Facial features and toe syndactyly distinguish STAR syndrome from TBS. STAR syndrome is caused by mutation of <i>FAM58A</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner with likely lethality in males.</p></div><div id="tbs.Management"><h2 id="_tbs_Management_">Management</h2><div id="tbs.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Townes-Brocks syndrome (TBS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div><b>Hearing.</b> Hearing evaluation as soon as the diagnosis of TBS is suspected (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>)</div></li><li class="half_rhythm"><div><b>Kidneys.</b> Renal ultrasound examination and routine laboratory tests for renal function</div></li><li class="half_rhythm"><div><b>Heart.</b> Baseline evaluation by a cardiologist including an echocardiogram</div></li><li class="half_rhythm"><div><b>Eyes.</b> Ophthalmology examination to evaluate for ocular features of TBS and atypical finding of Duane anomaly.</div></li><li class="half_rhythm"><div><b>Other.</b> Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="tbs.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following are indicated:</p><ul><li class="half_rhythm"><div><b>Imperforate anus.</b> Immediate surgical intervention is required.</div></li><li class="half_rhythm"><div><b>Hearing loss.</b> Significant impairment requires early treatment, typically with hearing aids (see <a href="/books/n/gene/deafness-overview/">Deafness and Hereditary Hearing Loss Overview</a>).</div></li><li class="half_rhythm"><div><b>Thumb malformations.</b> Severe malformations of the hands may require surgery (e.g., removal of additional thumbs).</div></li><li class="half_rhythm"><div><b>Renal.</b> Impaired renal function requires continuous monitoring, hemodialysis, and possibly kidney transplantation.</div></li><li class="half_rhythm"><div><b>Heart defects.</b> Congenital heart defects may require surgery or medical treatment by a cardiologist.</div></li></ul></div><div id="tbs.Surveillance"><h3>Surveillance</h3><p>Annual hearing evaluation is indicated.</p><p>Renal function should be regularly monitored in all individuals with and without renal anomalies, even if no impairment of renal function is detected on initial examination.</p></div><div id="tbs.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Medications that cause renal or otic toxicity should be avoided.</p></div><div id="tbs.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures.</p><ul><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk relatives.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known, clinical evaluation for physical features, hearing problems, renal disease, and heart defects can be used to clarify the disease status of at-risk relatives.</div></li></ul><p>See <a href="#tbs.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="tbs.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="tbs.Genetic_Counseling"><h2 id="_tbs_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="tbs.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Townes-Brocks syndrome (TBS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="tbs.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>About 50% of individuals diagnosed with TBS resulting from a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; about 50% have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant [Kohlhase, unpublished observation].</div></li><li class="half_rhythm"><div><i>De novo</i>
<i>SALL1</i> pathogenic variants most commonly occur (~87.5%) on the paternally derived <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 16 without an obvious age effect [<a class="bk_pop" href="#tbs.REF.b_hm.2006.1904">B&#x000f6;hm et al 2006</a>].</div></li><li class="half_rhythm"><div>If the <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband. Three individuals with mosaicism including the germline have been reported [<a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.blanck.2000.303">Blanck et al 2000</a>, <a class="bk_pop" href="#tbs.REF.devriendt.2002.230">Devriendt et al 2002</a>].</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> or physical examination, examination of the limbs (x-rays of the forearms, inspection of the feet) and ears, a hearing test, ultrasound examination of the kidneys and laboratory tests for renal function, and heart examination.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with TBS may appear to be negative because of failure to recognize the disorder in family members. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations (e.g., <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, physical examination) have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Clinical signs in parents with somatic mosaicism for a pathogenic variant may be as mild as toes II and IV overlapping the third toe [<a class="bk_pop" href="#tbs.REF.devriendt.2002.230">Devriendt et al 2002</a>].</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50%. With the exception of the <a class="figpopup" href="/books/NBK1445/table/tbs.T.sall1_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figtbsTsall1pathogenicvariantsdiscusse" rid-ob="figobtbsTsall1pathogenicvariantsdiscusse">p.Arg276Ter</a> pathogenic variant, which has caused a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in all known instances, results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> cannot predict which manifestations will be present or their severity.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be about 1%-2% because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [Kohlhase, unpublished observation].</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with Townes-Brocks syndrome has a 50% chance of inheriting the <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="tbs.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#tbs.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant, it is likely that the proband has a <i>de novo</i> variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="tbs.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Fetus with high a priori risk.</b> If the <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk is possible.</p><p>Although this testing can determine whether or not the fetus has inherited the <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it cannot predict which manifestations will be present or their severity, with the exception of the <a class="figpopup" href="/books/NBK1445/table/tbs.T.sall1_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figtbsTsall1pathogenicvariantsdiscusse" rid-ob="figobtbsTsall1pathogenicvariantsdiscusse">p.Arg276Ter</a> pathogenic variant, which has caused a severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in all known instances. High-resolution ultrasound examination is therefore recommended to evaluate the fetus for phenotypic manifestations. In a study of families with the pathogenic variant p.Arg276Ter, a fetus at risk was found to have a complex heart defect, preaxial polydactyly, foot malformations, and preauricular tags, suggesting TBS as the diagnosis [<a class="bk_pop" href="#tbs.REF.kohlhase.2003.e127">Kohlhase et al 2003</a>].</p><p><b>Fetus with low a priori risk.</b> If a fetus at no known increased risk for TBS has what appear to be features of classic TBS detected as early as the 16th week of pregnancy by a combination of high-resolution ultrasound and 3D ultrasound examinations, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>SALL1</i> can confirm the diagnosis.</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p><b>Preimplantation genetic diagnosis (PGD)</b> may be an option for families in which the <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified.</p></div></div><div id="tbs.Resources"><h2 id="_tbs_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=townesbrockssyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Townes-Brocks Syndrome</a></div></li><li class="half_rhythm"><div><b>Alexander Graham Bell Association for the Deaf and Hard of Hearing</b></div><div>3417 Volta Place Northwest</div><div>Washington DC 20007</div><div><b>Phone:</b> 866-337-5220 (toll-free); 202-337-5220; 202-337-5221 (TTY)</div><div><b>Fax:</b> 202-337-8314</div><div><b>Email:</b> info@agbell.org</div><div><a href="http://www.agbell.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Listening and Spoken Language Knowledge Center</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001147.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Imperforate anus</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li><li class="half_rhythm"><div><b>National Eye Institute</b></div><div>31 Center Drive</div><div>MSC 2510</div><div>Bethesda MD 20892-2510</div><div><b>Phone:</b> 301-496-5248</div><div><b>Email:</b> 2020@nei.nih.gov</div><div><a href="https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/low-vision" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Low Vision</a></div></li></ul></div><div id="tbs.Molecular_Genetics"><h2 id="_tbs_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="tbs.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Townes-Brocks Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1445/table/tbs.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbs.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_tbs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_tbs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_tbs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_tbs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_tbs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_tbs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_tbs.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6299" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SALL1</i></a></td><td headers="hd_b_tbs.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6299" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q12<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_tbs.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NSC2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Sal-like protein 1</a></td><td headers="hd_b_tbs.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SALL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SALL1 database</a></td><td headers="hd_b_tbs.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SALL1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SALL1</a></td><td headers="hd_b_tbs.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SALL1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SALL1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="tbs.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="tbs.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Townes-Brocks Syndrome (<a href="/omim/107480,602218" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1445/table/tbs.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbs.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/107480" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">107480</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TOWNES-BROCKS SYNDROME 1; TBS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602218" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602218</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SAL-LIKE 1; SALL1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>SALL1</i> occupies about 14.1 kb (start codon to stop codon). It contains four exons (all coding, two alternate first exons) and two introns. The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> sequence is <a href="/nuccore/NC_000016.10?from=51135975&#x00026;to=51152314&#x00026;report=genbank&#x00026;strand=true" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NC_000016.10</a>.</p><p><b>Benign variants.</b> More than 29 different non-pathogenic polymorphisms are currently known [<a class="bk_pop" href="#tbs.REF.b_hm.2006.1904">B&#x000f6;hm et al 2006</a>].</p><p><b>Pathogenic variants.</b> All reported and confirmed pathogenic variants are truncating and located in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 2 of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#tbs.REF.kohlhase.1998.81">Kohlhase et al 1998</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.marlin.1999.377">Marlin et al 1999</a>, <a class="bk_pop" href="#tbs.REF.blanck.2000.303">Blanck et al 2000</a>, <a class="bk_pop" href="#tbs.REF.engels.2000.458">Engels et al 2000</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.2000.460">Kohlhase 2000</a>, <a class="bk_pop" href="#tbs.REF.salerno.2000.25">Salerno et al 2000</a>, <a class="bk_pop" href="#tbs.REF.surka.2001.250">Surka et al 2001</a>, <a class="bk_pop" href="#tbs.REF.devriendt.2002.230">Devriendt et al 2002</a>, <a class="bk_pop" href="#tbs.REF.kohlhase.2003.e127">Kohlhase et al 2003</a>, <a class="bk_pop" href="#tbs.REF.walter.2006.649">Walter et al 2006</a>, <a class="bk_pop" href="#tbs.REF.reardon.2007.2588">Reardon et al 2007</a>, <a class="bk_pop" href="#tbs.REF.van_den_akker.2009.812">van den Akker et al 2009</a>, <a class="bk_pop" href="#tbs.REF.choi.2010.1018">Choi et al 2010</a>, <a class="bk_pop" href="#tbs.REF.hwang.2014.1429">Hwang et al 2014</a>].</p><p>Forty-six out of the 56 known <i>SALL1</i> pathogenic variants (2013 data) were located between the coding regions for the glutamine-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> mediating SALL protein interactions and 65 bp 3' of the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> for the first double zinc finger domain, narrowing the <i>SALL1</i> mutational <a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> region to a stretch of 802 bp within <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2.</p><p>Based on studies in mouse and chicken [<a class="bk_pop" href="#tbs.REF.kiefer.2003.2221">Kiefer et al 2003</a>, <a class="bk_pop" href="#tbs.REF.sweetman.2003.6560">Sweetman et al 2003</a>], it appears likely that the pathogenic variants escape <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated messenger decay and therefore do not result in <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of the protein encoded by <i>SALL1</i>. However, three families in whom larger deletions partially or completely removing <i>SALL1</i> clearly result in TBS have been described [<a class="bk_pop" href="#tbs.REF.borozdin.2006.211">Borozdin et al 2006</a>]. One family had a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of all exons, one had deletion of the entire <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and several neighboring genes, and one had deletion of <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 2 and partial deletion of exons 2 and 3. These findings confirm that SALL1 haploinsufficiency can cause the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, but it appears that the phenotype associated with larger deletions is at least milder than that of c.826C&#x0003e;T (though not milder than the phenotype associated with several other single-nucleotide variants).</p><div id="tbs.T.sall1_pathogenic_variants_discusse" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>SALL1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1445/table/tbs.T.sall1_pathogenic_variants_discusse/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tbs.T.sall1_pathogenic_variants_discusse_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.826C&#x0003e;T</td><td headers="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg276Ter</td><td headers="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_002968.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002968<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3160C&#x0003e;T</td><td headers="hd_h_tbs.T.sall1_pathogenic_variants_discusse_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg1054Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SALL1</i> encodes a C2H2 zinc finger protein of the SAL type, similar to the SAL protein encoded by the <i>Drosophila</i> gene <i>spalt</i>. It contains four double zinc finger domains characteristically distributed over the protein. There are also two single zinc fingers, a C2HC <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at the N terminus and a C2H2 finger attached to the second double zinc finger. <i>SALL1</i> is found strictly in the cell nucleus; it binds to heterochromatic foci and contains repressor domains at the N-terminus and in the central region [<a class="bk_pop" href="#tbs.REF.netzer.2001.3017">Netzer et al 2001</a>, <a class="bk_pop" href="#tbs.REF.netzer.2006.386">Netzer et al 2006</a>]. Expression of <i>csal1</i> (the chick ortholog of <i>SALL1</i>) in the limb is activated by ectopic SHH. However, this activation requires signals from the apical ectodermal ridge and involves FGF4/8 as well as Wnt3a and Wnt7a [<a class="bk_pop" href="#tbs.REF.farrell.2000.447">Farrell &#x00026; Munsterberg 2000</a>], showing that <i>csal1</i> expression is under control of at least three different pathways. In zebrafish, the <i>SALL1</i> homolog <i>sall1a</i> is regulated by <i>tbx5</i> and required for <i>fgf10</i> and <i>fgfr2</i> expression in the posterior pectoral fin bud [<a class="bk_pop" href="#tbs.REF.harvey.2006.1165">Harvey &#x00026; Logan 2006</a>]. In the mouse, Sall1 was found to enhance the canonical Wnt signaling pathway by localizing to pericentromeric heterochromatin [<a class="bk_pop" href="#tbs.REF.sato.2004.103">Sato et al 2004</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> All <i>SALL1</i> pathogenic variants (except for the larger deletions) detected in persons with TBS to date result in premature stop codons. Since transcripts with a premature stop codon are in most instances rapidly degraded, these pathogenic variants are a priori likely to cause TBS via SALL1 <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> [<a class="bk_pop" href="#tbs.REF.hentze.1999.307">Hentze &#x00026; Kulozik 1999</a>, <a class="bk_pop" href="#tbs.REF.maquat.2004.89">Maquat 2004</a>]. Proof for SALL1 haploinsufficiency being involved in the pathogenesis of human TBS came from the recent detection of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> 75-kb <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the entire <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> in a family with TBS [<a class="bk_pop" href="#tbs.REF.borozdin.2006.211">Borozdin et al 2006</a>].</p><p>However, the <i>Sall1</i> knock-out mouse showed that loss of Sall1 function does not result in defects that affect tissues other than kidney [<a class="bk_pop" href="#tbs.REF.nishinakamura.2001.3105">Nishinakamura et al 2001</a>]. Introducing a TBS <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in mouse <i>Sall1</i> instead leads to a TBS-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, and the detection of truncated Sall1 proteins points to a role of those proteins in the pathogenesis of TBS [<a class="bk_pop" href="#tbs.REF.kiefer.2003.2221">Kiefer et al 2003</a>]. In the zebrafish, <i>sall1a</i> loss of function leads to defective limb development, which can be aggravated by concomitant knock-down of <i>sall4</i> [<a class="bk_pop" href="#tbs.REF.harvey.2006.1165">Harvey &#x00026; Logan 2006</a>].</p><p>Comparison of the phenotypes associated with a <i>SALL1</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or with the severe <a class="figpopup" href="/books/NBK1445/table/tbs.T.sall1_pathogenic_variants_discusse/?report=objectonly" target="object" rid-figpopup="figtbsTsall1pathogenicvariantsdiscusse" rid-ob="figobtbsTsall1pathogenicvariantsdiscusse">p.Arg276Ter</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> indicate that the malformations in the family with the 75-kb deletion were relatively mild [<a class="bk_pop" href="#tbs.REF.borozdin.2006.211">Borozdin et al 2006</a>]. It could therefore be that <i>SALL1</i> deletions (i.e., SALL1 <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>) cause milder phenotypes than truncating pathogenic variants. This would require that mutated <i>SALL1</i> transcripts with premature stop codons escape the NMD pathway and lead to truncated proteins similar to those detected in mice. However, truncated SALL1 proteins have not been found in lymphoblastoid and amniotic fluid cells of persons with TBS [Kohlhase &#x00026; Rauchman, unpublished data], possibly because tissues most strongly expressing <i>SALL1</i> in the adult (brain and kidney) have not been accessible for investigation.</p><p>Csal (chicken) and Sall (mouse) proteins can interact with each other via mediation of an N-terminal glutamine-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> conserved in all known Sal proteins. Expression of truncated Sall1/ csal1 proteins is detected throughout the cell and not confined to the nucleus as full-length Sall1. Truncated Sall1 can interact with full-length Sall proteins and cause their displacement from the nucleus [<a class="bk_pop" href="#tbs.REF.kiefer.2003.2221">Kiefer et al 2003</a>, <a class="bk_pop" href="#tbs.REF.sweetman.2003.6560">Sweetman et al 2003</a>].</p><p>Alleles resulting from <i>SALL1</i> pathogenic variants in the 5' region of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 encode for truncated proteins with strong repressor activity but without the central repression and heterochromatin localization <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#tbs.REF.netzer.2006.386">Netzer et al 2006</a>]. Despite their potential to act as strong transcriptional repressors, these proteins will probably not localize to the physiologic site of action, but bind other SAL proteins and move them from the nucleus to the cytoplasm. Pathogenic variants further 3' in <i>SALL1</i> likely result in milder phenotypes than the 5' pathogenic variants [<a class="bk_pop" href="#tbs.REF.blanck.2000.303">Blanck et al 2000</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2005.282">Botzenhart et al 2005</a>]. If some of those pathogenic variants lead to truncated proteins including both repression domains and the heterochromatin localization domain, these proteins could still localize to their place of action and have some residual function, which could explain the milder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>The critical point in pathogenesis appears to be the correct dosage of functional SALL1 protein at the heterochromatic foci. A <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> results in a 50% reduction of this dosage. A 5' truncating <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> possibly leads to a truncated protein, which does not reach its site of action and in addition probably even removes some full-length protein of the normal allele from the nucleus. Therefore, in most instances the more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the 5' truncating pathogenic variants may result from a greater than 50% reduction of the functional protein at the site of action.</p><p>The additive <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the combined <i>sall4</i> and <i>sall1a</i> knock-down in zebrafish suggests that both genes may be able to compensate to some extent for each other. In view of the additive effects of <i>sall1a</i> and <i>sall4</i> knock-down on limb development it remains unclear if the TBS phenotype in humans is only caused by loss of SALL1 function or also by an effect of the hypothetic truncated SALL1 proteins on the function of other SALL proteins.</p><p>As the interaction between truncated SALL1 and functional SALL1 or other SALL proteins and the relocalization of the functional proteins requires the presence of the evolutionarily conserved glutamine-rich region in the amino-terminal part of the truncated protein, the effect of the <i>SALL1</i> pathogenic variants c.419delC and c.313delA, which would result in truncated proteins lacking the interaction <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, still needs to be explained, since the phenotypes associated with these pathogenic variants did not appear milder than the phenotypes resulting from other pathogenic variants [<a class="bk_pop" href="#tbs.REF.kohlhase.1999.435">Kohlhase et al 1999</a>, <a class="bk_pop" href="#tbs.REF.botzenhart.2007.204">Botzenhart et al 2007</a>].</p><p>Interestingly, 47 (82.5%) of 57 smaller pathogenic variants (2013 data) cluster within the 802-bp refined "<a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a> region" between the coding sequence for the glutamine-rich <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and the coding sequence for the first double zinc finger, whereas only two pathogenic variants were found within the remaining 763 bp upstream in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, and only six within the 2.4-kb coding region to the 3' end. Therefore, the existence of truncated proteins in cells of persons with TBS would not be surprising. If it holds true that <i>SALL1</i> single-nucleotide pathogenic variants lead to truncated SALL1 proteins with <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> action, one could expect that all truncated proteins have at least slightly different characteristics. This could explain the considerable phenotypic variability observed in TBS.</p></div><div id="tbs.References"><h2 id="_tbs_References_">References</h2><div id="tbs.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.albrecht.2004.102">Albrecht B, Liebers M, Kohlhase J. Atypical phenotype and intrafamilial variability associated with a novel SALL1 mutation. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">125A</span>:102–4.</span> [<a href="/pubmed/14755477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14755477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.bardakjian.2009.137">Bardakjian TM, Schneider AS, Ng D, Johnston JJ, Biesecker LG. Association of a de novo 16q copy number variant with a phenotype that overlaps with Lenz microphthalmia and Townes-Brocks syndromes. <span><span class="ref-journal">BMC Med Genet. </span>2009;<span class="ref-vol">10</span>:137.</span> [<a href="/pmc/articles/PMC2806267/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2806267</span></a>] [<a href="/pubmed/20003547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20003547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.blanck.2000.303">Blanck C, Kohlhase J, Engels S, Burfeind P, Engel W, Bottani A, Patel MS, Kroes HY, Cobben JM. Three novel SALL1 mutations extend the mutational spectrum in Townes-Brocks syndrome. <span><span class="ref-journal">J Med Genet. </span>2000;<span class="ref-vol">37</span>:303–7.</span> [<a href="/pmc/articles/PMC1734570/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734570</span></a>] [<a href="/pubmed/10819639" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10819639</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.b_hm.2006.1904">B&#x000f6;hm J, Munk-Schulenburg S, Felscher S, Kohlhase J. SALL1 mutations in sporadic Townes-Brocks syndrome are of predominantly paternal origin without obvious paternal age effect. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1904–8.</span> [<a href="/pubmed/16892410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16892410</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.borozdin.2006.211">Borozdin W, Steinmann K, Albrecht B, Bottani A, Devriendt K, Leipoldt M, Kohlhase J. Detection of heterozygous SALL1 deletions by quantitative real time PCR proves the contribution of a SALL1 dosage effect in the pathogenesis of Townes-Brocks syndrome. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:211–2.</span> [<a href="/pubmed/16429401" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16429401</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.borozdin.2004.e102">Borozdin W, Wright M, Hennekam R, Hannibal M, Crow Y, Neumann T, Kohlhase J. Novel mutations in the gene SALL4 provide further evidence for Acro-Renal-Ocular and Okihiro syndromes being allelic entities, and extend the phenotypic spectrum. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:e102.</span> [<a href="/pmc/articles/PMC1735876/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735876</span></a>] [<a href="/pubmed/15286162" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15286162</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.botzenhart.2007.204">Botzenhart EM, Bartalini G, Blair E, Brady AF, Elmslie F, Chong KL, Christy K, Torres-Martinez W, Danesino C, Deardorff MA, Fryns JP, Marlin S, Garcia-Minaur S, Hellenbroich Y, Hay BN, Penttinen M, Shashi V, Terhal P, Van Maldergem L, Whiteford ML, Zackai E, Kohlhase J. Townes-Brocks syndrome: twenty novel SALL1 mutations in sporadic and familial cases and refinement of the SALL1 hot spot region. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:204–5.</span> [<a href="/pubmed/17221874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17221874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.botzenhart.2005.282">Botzenhart EM, Green A, Ilyina H, Konig R, Lowry RB, Lo IF, Shohat M, Burke L, McGaughran J, Chafai R, Pierquin G, Michaelis RC, Whiteford ML, Simola KO, R&#x000f6;sler B, Kohlhase J. SALL1 mutation analysis in Townes-Brocks syndrome: twelve novel mutations and expansion of the phenotype. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">26</span>:282.</span> [<a href="/pubmed/16088922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16088922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.choi.2010.1018">Choi WI, Kim JH, Yoo HW, Oh SH. A family with Townes-Brocks syndrome with congenital hypothyroidism and a novel mutation of the SALL1 gene. <span><span class="ref-journal">Korean J Pediatr. </span>2010;<span class="ref-vol">53</span>:1018–21.</span> [<a href="/pmc/articles/PMC3021728/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3021728</span></a>] [<a href="/pubmed/21253317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21253317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.devriendt.2002.230">Devriendt K, Fryns JP, Lemmens F, Kohlhase J, Liebers M. Somatic mosaicism and variable expression of Townes-Brocks syndrome. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">111</span>:230–1.</span> [<a href="/pubmed/12210359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12210359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.engels.2000.458">Engels S, Kohlhase J, McGaughran J. A SALL1 mutation causes a branchio-oto-renal syndrome-like phenotype. <span><span class="ref-journal">J Med Genet. </span>2000;<span class="ref-vol">37</span>:458–60.</span> [<a href="/pmc/articles/PMC1734618/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734618</span></a>] [<a href="/pubmed/10928856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10928856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.farrell.2000.447">Farrell ER, Munsterberg AE. csal1 is controlled by a combination of FGF and Wnt signals in developing limb buds. <span><span class="ref-journal">Dev Biol. </span>2000;<span class="ref-vol">225</span>:447–58.</span> [<a href="/pubmed/10985862" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10985862</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.feichtiger.1943">Feichtiger H. A new malformation disorder primarily affecting the extremities. Germany: Medical Dissertation; 1943.</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.gabrielli.1993.459">Gabrielli O, Bonifazi V, Offidani AM, Cellini A, Coppa GV, Giorgi PL. Description of a patient with difficult nosological classification: Goldenhar syndrome or Townes-Brocks syndrome? <span><span class="ref-journal">Minerva Pediatr. </span>1993;<span class="ref-vol">45</span>:459–62.</span> [<a href="/pubmed/8133838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8133838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.harvey.2006.1165">Harvey SA, Logan MP. sall4 acts downstream of tbx5 and is required for pectoral fin outgrowth. <span><span class="ref-journal">Development. </span>2006;<span class="ref-vol">133</span>:1165–73.</span> [<a href="/pubmed/16501170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16501170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.hentze.1999.307">Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. <span><span class="ref-journal">Cell. </span>1999;<span class="ref-vol">96</span>:307–10.</span> [<a href="/pubmed/10025395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10025395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.hwang.2014.1429">Hwang DY, Dworschak GC, Kohl S, Saisawat P, Vivante A, Hilger AC, Reutter HM, Soliman NA, Bogdanovic R, Kehinde EO, Tasic V, Hildebrandt F. Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. <span><span class="ref-journal">Kidney Int. </span>2014;2014;<span class="ref-vol">85</span>:1429–33.</span> [<a href="/pmc/articles/PMC4040148/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4040148</span></a>] [<a href="/pubmed/24429398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24429398</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.johnson.1996.134">Johnson JP, Poskanzer LS, Sherman S. Three-generation family with resemblance to Townes-Brocks syndrome and Goldenhar/oculoauriculovertebral spectrum. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">61</span>:134–9.</span> [<a href="/pubmed/8669439" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8669439</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.keegan.2001.310">Keegan CE, Mulliken JB, Wu BL, Korf BR. Townes-Brocks syndrome versus expanded spectrum hemifacial microsomia: review of eight patients and further evidence of a "hot spot" for mutation in the SALL1 gene. <span><span class="ref-journal">Genet Med. </span>2001;<span class="ref-vol">3</span>:310–3.</span> [<a href="/pubmed/11478532" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11478532</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kiefer.2003.2221">Kiefer SM, Ohlemiller KK, Yang J, McDill BW, Kohlhase J, Rauchman M. Expression of a truncated Sall1 transcriptional repressor is responsible for Townes-Brocks syndrome birth defects. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:2221–7.</span> [<a href="/pubmed/12915476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12915476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kohlhase.2000.460">Kohlhase J. SALL1 mutations in Townes-Brocks syndrome and related disorders. <span><span class="ref-journal">Hum Mutat. </span>2000;<span class="ref-vol">16</span>:460–6.</span> [<a href="/pubmed/11102974" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11102974</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kohlhase.2002.2979">Kohlhase J, Heinrich M, Schubert L, Liebers M, Kispert A, Laccone F, Turnpenny P, Winter RM, Reardon W. Okihiro syndrome is caused by SALL4 mutations. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:2979–87.</span> [<a href="/pubmed/12393809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12393809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kohlhase.2003.e127">Kohlhase J, Liebers M, Backe J, Baumann-M&#x000fc;ller A, Bembea M, Destr&#x000e9;e A, Gattas M, Gr&#x000fc;ssner S, M&#x000fc;ller T, Mortier G, Skrypnyk C, Yano S, Wirbelauer J, Michaelis RC. High incidence of the R276X SALL1 mutation in sporadic but not familial Townes-Brocks syndrome and report of the first familial case. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:e127.</span> [<a href="/pmc/articles/PMC1735324/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735324</span></a>] [<a href="/pubmed/14627694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14627694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kohlhase.1999.435">Kohlhase J, Taschner PE, Burfeind P, Pasche B, Newman B, Blanck C, Breuning MH, ten Kate LP, Maaswinkel-Mooy P, Mitulla B, Seidel J, Kirkpatrick SJ, Pauli RM, Wargowski DS, Devriendt K, Proesmans W, Gabrielli O, Coppa GV, Wesby-van Swaay E, Trembath RC, Schinzel AA, Reardon W, Seemanova E, Engel W. Molecular analysis of SALL1 mutations in Townes-Brocks syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">64</span>:435–45.</span> [<a href="/pmc/articles/PMC1377753/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1377753</span></a>] [<a href="/pubmed/9973281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9973281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kohlhase.1998.81">Kohlhase J, Wischermann A, Reichenbach H, Froster U, Engel W. Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. <span><span class="ref-journal">Nat Genet. </span>1998;<span class="ref-vol">18</span>:81–3.</span> [<a href="/pubmed/9425907" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9425907</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.kurnit.1978.270">Kurnit DM, Steele MW, Pinsky L, Dibbins A. Autosomal dominant transmission of a syndrome of anal, ear, renal, and radial congenital malformations. <span><span class="ref-journal">J Pediatr. </span>1978;<span class="ref-vol">93</span>:270–3.</span> [<a href="/pubmed/671168" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 671168</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.lawrence.2013.2266">Lawrence C, Hong-McAtee I, Hall B, Hartsfield J, Rutherford A, Bonilla T, Bay C. Endocrine abnormalities in Townes-Brocks syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:2266–73.</span> [<a href="/pmc/articles/PMC5094807/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5094807</span></a>] [<a href="/pubmed/23894113" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23894113</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.maquat.2004.89">Maquat LE. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. <span><span class="ref-journal">Nat Rev Mol Cell Biol. </span>2004;<span class="ref-vol">5</span>:89–99.</span> [<a href="/pubmed/15040442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15040442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.marlin.1999.377">Marlin S, Blanchard S, Slim R, Lacombe D, Denoyelle F, Alessandri JL, Calzolari E, Drouin-Garraud V, Ferraz FG, Fourmaintraux A, Philip N, Toublanc JE, Petit C. Townes-Brocks syndrome: detection of a SALL1 mutation hot spot and evidence for a position effect in one patient. <span><span class="ref-journal">Hum Mutat. </span>1999;<span class="ref-vol">14</span>:377–86.</span> [<a href="/pubmed/10533063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10533063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.mart_nezfr_as.1999">Mart&#x000ed;nez-Fr&#x000ed;as ML, Bermejo S&#x000e1;nchez E, Arroyo Carrera I, P&#x000e9;rez Fern&#x000e1;ndez JL, Pardo Romero M, Bur&#x000f3;n Mart&#x000ed;nez E, Hern&#x000e1;ndez Ram&#x000f3;n F. The Townes-Brocks syndrome in Spain: the epidemiological aspects in a consecutive series of cases An Esp Pediatr. 1999;50:57-60. [<a href="/pubmed/10083645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10083645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.miller.2012.533">Miller EM, Hopkin R, Bao L, Ware SM. Implications for genotype-phenotype predictions in Townes-Brocks syndrome: case report of a novel SALL1 deletion and review of the literature. <span><span class="ref-journal">Am J Med Genet A. </span>2012;2012;<span class="ref-vol">158A</span>:533–40.</span> [<a href="/pubmed/22308078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22308078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.monteiro_de_pinaneto.1984.147">Monteiro de Pina-Neto J. Phenotypic variability in Townes-Brocks syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1984;<span class="ref-vol">18</span>:147–52.</span> [<a href="/pubmed/6741990" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6741990</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.netzer.2006.386">Netzer C, Bohlander SK, Hinzke M, Chen Y, Kohlhase J. Defining the heterochromatin localization and repression domains of SALL1. <span><span class="ref-journal">Biochim Biophys Acta. </span>2006;<span class="ref-vol">1762</span>:386–91.</span> [<a href="/pubmed/16443351" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16443351</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.netzer.2001.3017">Netzer C, Rieger L, Brero A, Zhang CD, Hinzke M, Kohlhase J, Bohlander SK. SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin. <span><span class="ref-journal">Hum Mol Genet. </span>2001;<span class="ref-vol">10</span>:3017–24.</span> [<a href="/pubmed/11751684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11751684</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.nishinakamura.2001.3105">Nishinakamura R, Matsumoto Y, Nakao K, Nakamura K, Sato A, Copeland NG, Gilbert DJ, Jenkins NA, Scully S, Lacey DL, Katsuki M, Asashima M, Yokota T. Murine homolog of SALL1 is essential for ureteric bud invasion in kidney development. <span><span class="ref-journal">Development. </span>2001;<span class="ref-vol">128</span>:3105–15.</span> [<a href="/pubmed/11688560" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11688560</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.reardon.2007.2588">Reardon W, Casserly LF, Birkenh&#x000e4;ger R, Kohlhase J. Kidney failure in Townes-Brocks syndrome: an under recognized phenomenon? <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:2588–91.</span> [<a href="/pubmed/17910067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17910067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.salerno.2000.25">Salerno A, Kohlhase J, Kaplan BS. Townes-Brocks syndrome and renal dysplasia: a novel mutation in the SALL1 gene. <span><span class="ref-journal">Pediatr Nephrol. </span>2000;<span class="ref-vol">14</span>:25–8.</span> [<a href="/pubmed/10654325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10654325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.sato.2004.103">Sato A, Kishida S, Tanaka T, Kikuchi A, Kodama T, Asashima M, Nishinakamura R. Sall1, a causative gene for Townes-Brocks syndrome, enhances the canonical Wnt signaling by localizing to heterochromatin. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2004;<span class="ref-vol">319</span>:103–13.</span> [<a href="/pubmed/15158448" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15158448</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.shawsmith.2006.545">Shaw-Smith C. Oesophageal atresia, tracheo-oesophageal fistula, and the VACTERL association: review of genetics and epidemiology. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:545–54.</span> [<a href="/pmc/articles/PMC2564549/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564549</span></a>] [<a href="/pubmed/16299066" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16299066</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.surka.2001.250">Surka WS, Kohlhase J, Neunert CE, Schneider DS, Proud VK. Unique family with Townes-Brocks syndrome, SALL1 mutation, and cardiac defects. <span><span class="ref-journal">Am J Med Genet. </span>2001;<span class="ref-vol">102</span>:250–7.</span> [<a href="/pubmed/11484202" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11484202</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.sweetman.2003.6560">Sweetman D, Smith T, Farrell ER, Chantry A, Munsterberg A. The conserved glutamine-rich region of chick csal1 and csal3 mediates protein interactions with other spalt family members. Implications for Townes-Brocks syndrome. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:6560–6.</span> [<a href="/pubmed/12482848" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12482848</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.townes.1972.321">Townes PL, Brocks ER. Hereditary syndrome of imperforate anus with hand, foot, and ear anomalies. <span><span class="ref-journal">J Pediatr. </span>1972;<span class="ref-vol">81</span>:321–6.</span> [<a href="/pubmed/5042490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5042490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.van_den_akker.2009.812">van den Akker PC, van de Graaf R, Dooijes D, van Essen AJ. Somatic mosaicism for the SALL1 mutation p.Ser371X in full-blown Townes-Brocks syndrome with Duane anomaly. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:812–5.</span> [<a href="/pubmed/19291771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19291771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.vodopiutz.2013.612">Vodopiutz J, Zoller H, Fenwick AL, Arnhold R, Schmid M, Prayer D, M&#x000fc;ller T, Repa A, Pollak A, Aufricht C, Wilkie AO, Janecke AR. Homozygous SALL1 mutation causes a novel multiple congenital anomaly-mental retardation syndrome. <span><span class="ref-journal">J Pediatr. </span>2013;<span class="ref-vol">162</span>:612–7.</span> [<a href="/pmc/articles/PMC3757162/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3757162</span></a>] [<a href="/pubmed/23069192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23069192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tbs.REF.walter.2006.649">Walter KN, Greenhalgh KL, Newbury-Ecob RA, Kohlhase J. Mosaic trisomy 8 and Townes-Brocks syndrome due to a novel SALL1 mutation in the same patient. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:649–51.</span> [<a href="/pubmed/16470706" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470706</span></a>]</div></li></ul></div></div><div id="tbs.Chapter_Notes"><h2 id="_tbs_Chapter_Notes_">Chapter Notes</h2><div id="tbs.Author_Notes"><h3>Author Notes</h3><p>Dr Kohlhase&#x02019;s Web site: <a href="http://www.humangenetik-freiburg.de/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.humangenetik-freiburg.de</a></p></div><div id="tbs.Acknowledgments"><h3>Acknowledgments</h3><p>The author's research has received funding by the Deutsche Forschungsgemeinschaft (German National Science Foundation) and the Wilhelm-Sander-Stiftung, a German non-profit research foundation.</p></div><div id="tbs.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 January 2016 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>3 May 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>24 January 2007 (me) Review posted to live Web site</div></li><li class="half_rhythm"><div>17 November 2006 (jk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1445</span><span class="label">PMID: <a href="/pubmed/20301618" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301618</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/timothy/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tcs/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1445&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1445/?report=reader">PubReader</a></li><li><a href="/books/NBK1445/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1445" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1445" style="display:none" title="Cite this Page"><div class="bk_tt">Kohlhase J. Townes-Brocks Syndrome. 2007 Jan 24 [Updated 2016 Jan 14]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1445/pdf/Bookshelf_NBK1445.pdf">PDF version of this page</a> (444K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#tbs.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#tbs.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#tbs.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#tbs.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#tbs.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#tbs.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#tbs.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#tbs.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#tbs.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#tbs.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#tbs.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6299[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SALL1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1468456" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1468456" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1468456" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1468456" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301547" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SALL4</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SALL4</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kohlhase J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27073431" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Delayed diagnosis of Townes-Brocks syndrome with multicystic kidneys and renal failure caused by a novel &lt;i&gt;SALL1&lt;/i&gt; nonsense mutation: A case report.</a><span class="source">[Exp Ther Med. 2016]</span><div class="brieflinkpop offscreen_noflow">Delayed diagnosis of Townes-Brocks syndrome with multicystic kidneys and renal failure caused by a novel &lt;i&gt;SALL1&lt;/i&gt; nonsense mutation: A case report.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin FJ, Lu W, Gale D, Yao Y, Zou R, Bian F, Jiang GR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Exp Ther Med. 2016 Apr; 11(4):1249-1252. Epub 2016 Jan 29.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10051003" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Townes-Brocks syndrome.</a><span class="source">[J Med Genet. 1999]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Townes-Brocks syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Powell CM, Michaelis RC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Med Genet. 1999 Feb; 36(2):89-93. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10654325" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Townes-Brocks syndrome and renal dysplasia: a novel mutation in the SALL1 gene.</a><span class="source">[Pediatr Nephrol. 2000]</span><div class="brieflinkpop offscreen_noflow">Townes-Brocks syndrome and renal dysplasia: a novel mutation in the SALL1 gene.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Salerno A, Kohlhase J, Kaplan BS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Pediatr Nephrol. 2000 Jan; 14(1):25-8. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301501" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Polycystic Kidney Disease, Autosomal Recessive<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sweeney WE, Avner ED. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301618" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301618" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041575dd21425a250968e2">Townes-Brocks Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Townes-Brocks Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:05:41-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C820FE03F94C1000000000B1603CF&amp;ncbi_session=CE8C820FE0415751_2838SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1445%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1445&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1445/&amp;ncbi_pagename=Townes-Brocks Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C820FE0415751_2838SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>